|
|
Volumn 306, Issue 12, 2011, Pages 1311-1312
|
|
Questions about spine fusion product prompt a new process for reviewing data
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;
ACCESS TO INFORMATION;
BONE GRAFT;
CLINICAL TRIAL (TOPIC);
CONFLICT OF INTEREST;
DATA ANALYSIS;
DEVICE SAFETY;
DISEASE ASSOCIATION;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG SAFETY;
DYSPHAGIA;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INFORMATION PROCESSING;
INTERVERTEBRAL DISKECTOMY;
LUMBAR SPINE;
MEDICAL LITERATURE;
MEDICAL RESEARCH;
METHODOLOGY;
OFF LABEL DRUG USE;
PATIENT SAFETY;
PEER REVIEW;
POSTMARKETING SURVEILLANCE;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
SHORT SURVEY;
SPINE FUSION;
SPINE SURGERY;
TREATMENT OUTCOME;
UNITED STATES;
WOUND HEALING IMPAIRMENT;
|
|
EID: 80053205782
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2011.1371 Document Type: Short Survey |
|
Times cited : (5)
|
|
References (0)
|
